{
    "clinical_study": {
        "@rank": "121097", 
        "arm_group": [
            {
                "arm_group_label": "Light therapy", 
                "arm_group_type": "Experimental", 
                "description": "In this group, participants will be exposed to the LED treatment device (light box) which delivers bright light and meanwhile medicated with just one particular antipsychotics drug(a mood stabilizer or an atypical antipsychotic drug)except of antidepressants."
            }, 
            {
                "arm_group_label": "Control group", 
                "arm_group_type": "Placebo Comparator", 
                "description": "In this group, participants will be exposed to the same LED treatment device (light box) which delivers dim red light,which is considered to be biologically inactive, and meanwhile medicated with just one particular antipsychotics drug(a mood stabilizer or an atypical antipsychotic drug)except of antidepressants."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate the efficacy and safety of light-emitting\n      diode(LED) light therapy on Chinese patients with Depressive Episodes of Bipolar Disorder\n      and to gather prime research data and application parameters of LED light source which is\n      not currently available in China."
        }, 
        "brief_title": "A Clinical Study of Light Therapy on Depressive Episodes of Bipolar Disorder", 
        "condition": "Depressive Episodes of Bipolar Disorder", 
        "condition_browse": {
            "mesh_term": [
                "Bipolar Disorder", 
                "Depression", 
                "Depressive Disorder"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  ages 18 to 65 years\n\n          -  comply with the DSM-IV diagnosis of Bipolar I or II Disorder and a current depressive\n             episode\n\n          -  HAMD score \u226517 points\n\n          -  intake of just one particular psychotropic drug(a mood stabilizer or an atypical\n             antipsychotic drug) except of antidepressants and lasted 2 weeks.\n\n        Exclusion Criteria:\n\n          -  inability to provide informed consent;\n\n          -  previous treatment with BLT\n\n          -  presence of another major psychiatric illness such as schizophrenia, schizoaffective\n             disorder,  lifetime alcohol or substance dependence\n\n          -  diagnosed with a rapid-cycling bipolar disorder or currently in the mixed state or\n             YMRS score>12 points\n\n          -  use of antidepressants medications\n\n          -  significant medical illness such as diabetes mellitus,heart failure, renal failure,\n             severe liver function abnormalities,hyperthyroidism or hypothyroidism\n\n          -  pregnancy;\n\n          -  received magnified electroconvulsive therapy orRepetitive Transcranial Magnetic\n             Stimulation in the past 3 months\n\n          -  an eye condition that could be negatively affected by bright light\n\n          -  suicidal risk or other factor making trial participation clinically inappropriate."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02009371", 
            "org_study_id": "SF2011-4023-03"
        }, 
        "intervention": {
            "arm_group_label": "Light therapy", 
            "description": "In this group, participants will be exposed to the LED treatment device (lightbox) which delivers bright light and meanwhile medicated with just one particular antipsychotics drug(a mood stabilizer or an atypical antipsychotic drug)except of antidepressants.", 
            "intervention_name": "Light therapy", 
            "intervention_type": "Radiation"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Antidepressive Agents", 
                "Antipsychotic Agents"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "December 8, 2013", 
        "location": {
            "contact": {
                "email": "yuxin@bjmu.edu.cn", 
                "last_name": "Xin Yu, Professor", 
                "phone": "86-10-82801999"
            }, 
            "facility": {
                "address": {
                    "city": "Beijing", 
                    "country": "China", 
                    "state": "Beijing", 
                    "zip": "100191"
                }, 
                "name": "Mental Health Institute of Peking University"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "yuxin@bjmu.edu.cn", 
            "last_name": "Xin Yu, professor", 
            "phone": "86-10-82801999"
        }, 
        "overall_official": {
            "affiliation": "Peking University", 
            "last_name": "Xin Yu, professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ministry of Health"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "We used HAMD to evaluate the major state of depression.", 
            "measure": "Reducing rate of HAMD", 
            "safety_issue": "No", 
            "time_frame": "Change from baselin to 2 weeks after"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02009371"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Peking University", 
            "investigator_full_name": "Xin Yu", 
            "investigator_title": "President", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "We use CGI to evaluate the state of depression.", 
            "measure": "Reducing rate of CGI", 
            "safety_issue": "No", 
            "time_frame": "Change from baseline to 2 week after"
        }, 
        "source": "Peking University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Peking University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}